Drug Profile
Research programme: antileukotriene monoclonal antibodies - Lpath
Alternative Names: Altepan™; Anti-leukotriene antibody - Lpath; Leukotriene inhibitors - LpathLatest Information Update: 27 Apr 2023
Price :
$50
*
At a glance
- Originator Lpath
- Class Monoclonal antibodies
- Mechanism of Action Leukotriene inhibitors
-
Orphan Drug Status
Orphan designation is assigned by a regulatory body to encourage companies to develop drugs for rare diseases.
- New Molecular Entity No
- Available For Licensing Yes - Asthma; Inflammatory bowel diseases
Highest Development Phases
- Discontinued Asthma; Inflammation; Inflammatory bowel diseases; Respiratory tract disorders
Most Recent Events
- 27 Apr 2023 Discontinued - Preclinical for Asthma in USA (Parenteral)
- 27 Apr 2023 Discontinued - Preclinical for Inflammation in USA (Parenteral)
- 27 Apr 2023 Discontinued - Preclinical for Inflammatory bowel diseases in USA (Parenteral)